Literature DB >> 16581297

The induction and maintenance of T cell anergy.

Jonathan D Powell1.   

Abstract

While the "true" role of T cell anergy in promoting peripheral tolerance continues to be debated, it is clear that studying the various models of anergy have led to important insight in terms of understanding the pathways and molecules responsible for T cell activation and inhibition. This review will examine our current understanding of CD4+ T cell anergy. In particular, it will focus on the signaling pathways responsible for both the induction and maintenance of anergy. Furthermore, it will examine how specifically targeting these pathways can be exploited clinically in terms of promoting tolerance in transplantation and autoimmunity and inhibiting tumor-induced tolerance in the case of tumor-immunotherapy.

Entities:  

Mesh:

Year:  2006        PMID: 16581297     DOI: 10.1016/j.clim.2006.02.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  21 in total

Review 1.  Cyclin-dependent kinases: molecular switches controlling anergy and potential therapeutic targets for tolerance.

Authors:  Andrew D Wells
Journal:  Semin Immunol       Date:  2007-03-23       Impact factor: 11.130

2.  A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.

Authors:  Paul E Zarek; Ching-Tai Huang; Eric R Lutz; Jeanne Kowalski; Maureen R Horton; Joel Linden; Charles G Drake; Jonathan D Powell
Journal:  Blood       Date:  2007-10-01       Impact factor: 22.113

3.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment.

Authors:  Greg M Delgoffe; Thomas P Kole; Yan Zheng; Paul E Zarek; Krystal L Matthews; Bo Xiao; Paul F Worley; Sara C Kozma; Jonathan D Powell
Journal:  Immunity       Date:  2009-06-19       Impact factor: 31.745

4.  FoxO-dependent regulation of diacylglycerol kinase α gene expression.

Authors:  Mónica Martínez-Moreno; Job García-Liévana; Denise Soutar; Pedro Torres-Ayuso; Elena Andrada; Xiao-Ping Zhong; Gary A Koretzky; Isabel Mérida; Antonia Ávila-Flores
Journal:  Mol Cell Biol       Date:  2012-08-13       Impact factor: 4.272

5.  Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth.

Authors:  Céline A Blache; Edwin R Manuel; Teodora I Kaltcheva; Andrea N Wong; Joshua D I Ellenhorn; Bruce R Blazar; Don J Diamond
Journal:  Cancer Res       Date:  2012-10-22       Impact factor: 12.701

6.  IL-2 signaling prevents T cell anergy by inhibiting the expression of anergy-inducing genes.

Authors:  Myrianne Duré; Fernando Macian
Journal:  Mol Immunol       Date:  2008-11-05       Impact factor: 4.407

7.  Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3.

Authors:  Sam Collins; Michael A Lutz; Paul E Zarek; Robert A Anders; Gilbert J Kersh; Jonathan D Powell
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

8.  Anergic T cells are metabolically anergic.

Authors:  Yan Zheng; Greg M Delgoffe; Christian F Meyer; Waipan Chan; Jonathan D Powell
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

9.  Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors.

Authors:  Edmund K Moon; Liang-Chuan Wang; Douglas V Dolfi; Caleph B Wilson; Raghuveer Ranganathan; Jing Sun; Veena Kapoor; John Scholler; Ellen Puré; Michael C Milone; Carl H June; James L Riley; E John Wherry; Steven M Albelda
Journal:  Clin Cancer Res       Date:  2014-06-11       Impact factor: 12.531

Review 10.  Immune mechanisms in thyroid eye disease.

Authors:  Geniece M Lehmann; Steven E Feldon; Terry J Smith; Richard P Phipps
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.